A reduced form of nicotinamide riboside defines a new path for NAD+ biosynthesis and acts as an orally bioavailable NAD+ precursor
Judith Giroud‐Gerbetant(École Polytechnique Fédérale de Lausanne), Carles Cantó(École Polytechnique Fédérale de Lausanne)
Cited by 132
Related Papers
CREB and ChREBP oppositely regulate SIRT1 expression in response to energy availability
|EMBO Reports|2011|167